skip to main content
Refined by: collection: Standalone journals remove resource type: Other remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Integrated Safety Summary of Single-Agent Mirvetuximab Soravtansine in Patients with Folate Receptor α (FRα) Positive Recurrent Ovarian Cancer: Phase 1 and 3 Clinical Trials
Material Type:
Other
Add to e-Shelf

Integrated Safety Summary of Single-Agent Mirvetuximab Soravtansine in Patients with Folate Receptor α (FRα) Positive Recurrent Ovarian Cancer: Phase 1 and 3 Clinical Trials

Moore, K ; Lorusso, D ; Oaknin, A ; Oza, A.M ; Colombo, N ; Van Gorp, Toon ; O'Malley, D.M ; Banerjee, S.N ; Murphy, C.G ; Harter, P ; Konecny, G.E ; Pautier, P ; Method, M.W ; Wang, J ; Birrer, M.J ; Coleman, R.L ; Matulonis, U.A

Journal Of Clinical Oncology, 2022, Vol.40 (16_suppl), p.5574-5574

American Society of Clinical Oncology

Full text available

2
Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML
Material Type:
Other
Add to e-Shelf

Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML

Rio-Machin, Ana ; Bewicke-Copley, Findlay ; Zheng, Jiexin ; Izquierdo, Pedro Casado ; Miettinen, Juho J ; Khan, Naeem ; Demeulemeester, Jonas ; Krizsan, Szilvia ; Middleton, Christopher ; Benkwitz-Bedford, Sam ; Saad, Joseph ; Vilas-Zornoza, Amaia ; Ezponda, Teresa ; Grey, William ; Lavallee, Vincent-Philippe ; Nolin-Lapalme, Alexis ; Miraki-Moud, Farideh ; Matthews, Janet ; Grantham, Marianne ; Colm, Ryan J ; Bond, Jonathan ; Di Bella, Doriana ; Wennerberg, Krister ; Parsons, Alun ; Zeng, Andy G.X ; Armes, Hannah ; Close, Karina ; Kaya, Fadimana ; Rouault-Pierre, Kevin ; Gribben, John G ; Prosper, Felipe ; Cavenagh, James ; Dick, John E ; Freeman, Sylvie D ; Van Loo, Peter ; Bodor, Csaba ; Sauvageau, Guy ; Porkka, Kimmo ; Heckman, Caroline A ; Wang, Jun ; Cazier, Jean-Baptiste ; Taussig, David ; Bonnet, Dominique ; Cutillas, Pedro ; Fitzgibbon, Jude

BLOOD, 2022, Vol.140, p.1030-1032

AMER SOC HEMATOLOGY

Full text available

3
Safety and efficacy results from the expansion phase of the first-in-human study evaluating TGFß inhibitor SAR439459 alone and combined with cemiplimab in adults with advanced solid tumors
Material Type:
Other
Add to e-Shelf

Safety and efficacy results from the expansion phase of the first-in-human study evaluating TGFß inhibitor SAR439459 alone and combined with cemiplimab in adults with advanced solid tumors

Robbrecht, Debbie ; Doger, Bernard ; Grob, Jean-Jacques ; Bechter, Oliver Edgar ; De Miguel, Maria J ; Vieito, Maria ; Schadendorf, Dirk ; Curigliano, Giuseppe ; Borbath, Ivan ; Butler, Marcus O ; Rodriguez-Vida, Alejo ; Miller, Wilson H ; Lin, Tun Tun ; Masson, Nina ; Pouzin, Clemence ; Wang, Rui ; Demers, Brigitte ; Amrate, Amele ; Abbadessa, Giovanni ; Simonelli, Matteo

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16)

LIPPINCOTT WILLIAMS & WILKINS

Full text available

4
THERAPEUTIC DRUG MONITORING CAN GUIDE THE INTRAVENOUS-TO -SUBCUTANEOUS SWITCH OF INFLIXIMAB AND VEDOLIZUMAB: A PHARMACOKINETIC SIMULATION STUDY
Material Type:
Other
Add to e-Shelf

THERAPEUTIC DRUG MONITORING CAN GUIDE THE INTRAVENOUS-TO -SUBCUTANEOUS SWITCH OF INFLIXIMAB AND VEDOLIZUMAB: A PHARMACOKINETIC SIMULATION STUDY

Wang, Z ; Verstockt, B ; Sabino, J ; Ferrante, M ; Vermeire, S ; Dreesen, E

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, Vol.113, p.S48-S49

WILEY

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far